J. Goudsmit

发表

H5N1 Protection by Seasonal Influenza Vaccine in Homologous andHeterologous Prime/Boost Vaccination

Martin H. Koldijk, K. Radošević, A. Roos, 2015 .

Protection against H5N1 by multiple immunizations with seasonal influenza vaccine in mice is correlated with H5 cross-reactive antibodies.

K. Radošević, A. Roos, R. Roozendaal, 2015, Vaccine.

A common solution to group 2 influenza virus neutralization

Gira Bhabha, Damian C. Ekiert, Andrew B. Ward, 2013, Proceedings of the National Academy of Sciences.

A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen

Adrian Apetri, Liesbeth Dekking, Andrew B. Ward, 2015, Science.

Viral Sex: The Nature of AIDS

Jaap Goudsmit, J. Goudsmit, 1997 .

Improved Silica-Guanidiniumthiocyanate DNA Isolation Procedure Based on Selective Binding of Bovine Alpha-Casein to Silica Particles

J. Goudsmit, J. Weel, C. Sol, 1999, Journal of Clinical Microbiology.

Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment

J. Goudsmit, A. van den Hoek, R. Coutinho, 1993, AIDS.

Gene expression profile of AIDS-related Kaposi's sarcoma

Marion Cornelissen, Jaap Goudsmit, C. V. van Noesel, 2003, BMC Cancer.

Adenovirus-Specific Immunity Following Immunization with an Ad5 HIV-1 Vaccine Candidate in Humans

M. Betts, M. Lifton, J. Shiver, 2009, Nature Medicine.

Antibody Recognition of a Highly Conserved Influenza Virus Epitope

Gira Bhabha, Damian C. Ekiert, Jaap Goudsmit, 2009, Science.

A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses

Martin H. Koldijk, Gira Bhabha, Damian C. Ekiert, 2011, Science.

Two Distinct Gamma-2 Herpesviruses in African Green Monkeys: a Second Gamma-2 Herpesvirus Lineage among Old World Primates?

T. Schulz, S. Norley, J. Goudsmit, 2000, Journal of Virology.

Evidence for and against the transmissibility of Alzheimer disease

C. Masters, C. Masters, D. Gajdusek, 1980, Neurology.

Complete nucleotide sequence of simian endogenous type D retrovirus with intact genome organization: evidence for ancestry to simian retrovirus and baboon endogenous virus

J. Goudsmit, A. C. van der Kuyl, J Goudsmit, 1997, Journal of virology.

Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapy.

N M Ferguson, A. Ghani, C. Donnelly, 1999, Proceedings of the National Academy of Sciences of the United States of America.

In Vitro Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice

K. Subbarao, G. Weverling, J. Goudsmit, 2017, Journal of Virology.

Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters.

J. Goudsmit, M. Beld, N. Pakker, 1998, Virology.

Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution.

C. Kuiken, J. Goudsmit, G. Zwart, 1991, Virology.

Immune Control of an SIV Challenge by a T Cell-Based Vaccine in Rhesus Monkeys

D. Montefiori, K. Mansfield, G. Landucci, 2008, Nature.

Serum beta 2-microglobulin levels in asymptomatic HIV-1-infected subjects during long-term zidovudine treatment.

P. Krijnen, J. Goudsmit, M. Bakker, 1991, Genitourinary medicine.

Infection by zidovudine-resistant HIV-1 compromises the virological response to stavudine in a drug-naive patient.

M. V. van Dooren, J. Goudsmit, B. van Gemen, 2000, AIDS.

Refocusing neutralizing antibody response by targeted dampening of an immunological epitope

G. Rimmelzwaan, J. Goudsmit, A. Minassian, 2001 .

Further characterization of an antigenic site of HIV-1 gp120 recognized by virus neutralizing human monoclonal antibodies.

J. Sodroski, J. McKeating, J. Goudsmit, 1993, AIDS.

Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy.

C H Fox, H. Schuitemaker, C. Fox, 1999, AIDS.

An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization.

J. Goudsmit, M. Schutten, W. Keulen, 1994, Virology.

N-Linked Glycosylation of the HIV Type-1 gp120 Envelope Glycoprotein as a Major Determinant of CCR5 and CXCR4 Coreceptor Utilization*

Jaap Goudsmit, Georgios Pollakis, W. Paxton, 2001, The Journal of Biological Chemistry.

Differences in HIV type 1 RNA plasma load profile of closely related cocirculating Ethiopian subtype C strains: C and C'.

B. Berkhout, W. Paxton, J. Goudsmit, 2010, AIDS research and human retroviruses.

Lack of in vivo compartmentalization among HIV-1 infected naïve and memory CD4+ T cell subsets.

R. Koup, D. Douek, J. Brenchley, 2009, Virology.

Title Human monoclonal antibody combination against SARScoronavirus : Synergy and coverage of escape mutants

J. Peiris, L. Poon, H. Doerr, 2006 .

Multiple HIV-1 subtypes present amongst heterosexuals in Amsterdam 1988-1996: no evidence for spread of non-B subtypes.

J. Goudsmit, E. O. D. Op de Coul, V. Lukashov, 1998, AIDS.

Identification of a novel type C porcine endogenous retrovirus: evidence that copy number of endogenous retroviruses increases during host inbreeding.

X. Chen, J. Goudsmit, A. C. van der Kuyl, 2001, The Journal of general virology.

HIV‐1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment

B. Larder, C. Boucher, P. Kellam, 1992, AIDS.

Insertion of primary syncytium-inducing (SI) and non-SI envelope V3 loops in human immunodeficiency virus type 1 (HIV-1) LAI reduces neutralization sensitivity to autologous, but not heterologous, HIV-1 antibodies

J. Goudsmit, A. V. van Wijk, M. Bakker, 1995, Journal of virology.

Fine specificity of antibody recognition may predict amino acid substitution in the third variable region of gp120 during HIV type 1 infection.

R. Meloen, J. Goudsmit, J. Langedijk, 1995, AIDS research and human retroviruses.

Genomic diversity and antigenic variation of HIV‐1: links between pathogenesis, epidemiology and vaccine development

J. Goudsmit, P. Nara, N. Back, 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies.

C. Kuiken, L. Epstein, J. Goudsmit, 1991, Virology.

Predominance of HIV-1 serotype distinct from LAV-1/HTLV-IIIB

J. Goudsmit, G. Zwart, P. Nara, 1990, The Lancet.

Association of antibodies blocking HIV‐1 gp160‐sCD4 attachment with virus neutralizing activity in human sera

J. Goudsmit, N. Back, C. Bruck, 1990, Journal of medical virology.

UvA-DARE ( Digital Academic Repository ) New technologies for the control of influenza Koudstaal

C. McLeod, M. Havenga, W. Barclay, 2010 .

Rapid generation of a well-matched vaccine seed from a modern influenza A virus primary isolate without recourse to eggs.

C. McLeod, M. Havenga, W. Barclay, 2010, Vaccine.

Hemorrhagic fever virus infections in an isolated rainforest area of central Liberia. Limitations of the indirect immunofluorescence slide test for antibody screening in Africa.

D. Gajdusek, J. Goudsmit, K. Pomeroy, 1986, Tropical and geographical medicine.

Baboon endogenous virus evolution and ecology.

J. Goudsmit, A. C. van der Kuyl, J. Dekker, 1996, Trends in microbiology.

Isolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile Virus

M. Loeb, D. Kelvin, W. Preiser, 2006, Journal of Virology.

Temporal trends of the natural history of HIV-1 infection following seroconversion between 1984 and 1993.

I. Keet, P. Veugelers, J. Goudsmit, 1996, AIDS.

Lack of correlation between length variation in the DNA polymerase gamma gene CAG repeat and lactic acidosis or neuropathy during antiretroviral treatment.

J. Goudsmit, A. C. van der Kuyl, Xianghong Chen, 2002, AIDS research and human retroviruses.

HIV-1 RNA response to antiretroviral treatment in 1280 participants in the Delta Trial: an extended virology study.

D. Jeffries, A. Breckenridge, F. Brun-Vézinet, 1999, AIDS.

SARS Coronavirus Spike Protein Expression in HL-CZ Human Promonocytic Cells: Monoclonal Antibody and Cellular Transcriptomic Analyses

J. Goudsmit, J. T. ter Meulen, V. Chow, 2009, Molecular Biology of the SARS-Coronavirus.

The thymus in acquired immune deficiency syndrome. Comparison with other types of immunodeficiency diseases, and presence of components of human immunodeficiency virus type 1.

R. Broekhuizen, J. Goudsmit, H. Schuurman, 1989, The American journal of pathology.

A rapid method for immunotitration of influenza viruses using flow cytometry.

M. Havenga, J. Goudsmit, C. Ophorst, 2003, Journal of virological methods.

The role of a stromal cell‐derived factor‐1 chemokine gene variant in the clinical course of HIV‐1 infection

H. Schuitemaker, J. Goudsmit, R. V. van Rij, 1998, AIDS.

Running Title: AERAS-402 induces robust T cell immunity in adults

M. Tameris, J. McClain, G. Hussey, 2010 .

The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults.

M. Tameris, M. Hatherill, J. McClain, 2010, American journal of respiratory and critical care medicine.

Universal influenza vaccine design: directing the antibody repertoire

F. Cox, J. Juraszek, J. Goudsmit, 2016 .

Human Herpesvirus 8 Load in Matched Serum and Plasma Samples of Patients with AIDS-Associated Kaposi's Sarcoma

J. Goudsmit, M. Cornelissen, R. van den Burg, 2003, Journal of Clinical Microbiology.

, Jaap to Silica Particles Selective Binding of Bovine Alpha-Casein DNA Isolation Procedure Based on Improved Silica-Guanidiniumthiocyanate

J. Goudsmit, M. Beld, J. Weel, 1999 .

Characterization ofMurineMonoclonal Antibodies tothetatProtein fromHumanImmunodeficiency Virus Type1

C. Debouck, J. Goudsmit, P. Schammel, 1990 .

Transient Humoral Protection against H5N1 Challenge after Seasonal Influenza Vaccination of Humans

V. Klaren, G. Weverling, K. Radošević, 2014, PloS one.

Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354

M. Diamond, M. Rossmann, R. Kuhn, 2010, Proceedings of the National Academy of Sciences.

rBCG Induces Strong Antigen-Specific T Cell Responses in Rhesus Macaques in a Prime-Boost Setting with an Adenovirus 35 Tuberculosis Vaccine Vector

J. Andersson, J. Goudsmit, I. Magalhaes, 2008, PloS one.

Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigen-specific cellular IFN-gamma and antibody responses in mice.

V. A. Stewart, M. Demoitié, Joe D. Cohen, 2008, Vaccine.

Priming with an Adenovirus 35-Circumsporozoite Protein (CS) Vaccine followed by RTS,S/AS01B Boosting Significantly Improves Immunogenicity to Plasmodium falciparum CS Compared to That with Either Malaria Vaccine Alone

V. A. Stewart, M. Demoitié, Joe D. Cohen, 2007, Infection and Immunity.

External validity of phase III trials on vaccines against SARS-CoV-2 to a middle-aged and elderly Western European population

A. Hofman, M. Ikram, J. Goudsmit, 2020, European Journal of Epidemiology.

The incubation period of Alzheimer’s disease and the timing of tau versus amyloid misfolding and spreading within the brain

J. Goudsmit, 2016, European Journal of Epidemiology.

Mycobacterium tuberculosis Vaccination Imprints on T-Cell Dynamics Associated with Mycobacterium tuberculosis Challenge in Rhesus Monkeys

A. Thomas, F. Verreck, J. Andersson, 2012 .

Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients

M. Havenga, J. Goudsmit, D. Nanda, 2007, Cancer Gene Therapy.

In vitro assay for site-specific proteases using bead-attached GFP substrate.

J. Frelinger, J. Goudsmit, D. Patel, 2001, BioTechniques.

Epilepsy in the Gbawein and Wroughbarh Clan of Grand Bassa County, Liberia: The Endemic Occurrence of 'See-ee' in the Native Population

D. Gajdusek, J. Goudsmit, F. V. D. Waals, 1983 .

Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men.

R. Geskus, M. Prins, T. Schulz, 2000, American journal of epidemiology.

Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma

T. Schulz, G. Weverling, J. Goudsmit, 1998, AIDS.

Scrapie and its association with 'amyloid-like' fibrils and glycoproteins encoded by cellular genes: an animal model for human dementia.

J. Goudsmit, F. W. van der Waals, 1986, Progress in brain research.

Concordance of human immunodeficiency virus detection by polymerase chain reaction and by serologic assays in a Dutch cohort of seronegative homosexual men.

J. Goudsmit, F. de Wolf, S. Bruisten, 1992, The Journal of infectious diseases.

Sero-Epidemiology of the Human T-Lymphotropic Retroviruses HTLV-I and HTLV-III in the Netherlands

J. Goudsmit, 1985 .

Risk factors for human herpesvirus 8 infection in a cohort of drug users in the Netherlands, 1985-1996.

M. Prins, T. Schulz, G. Weverling, 2002, The Journal of infectious diseases.

Kaposi's sarcoma and human herpesvirus 8 infection do not protect HIV-1 infected homosexual men from AIDS dementia complex

P. Portegies, T. Schulz, G. Weverling, 2001, AIDS.

Protective Immune Responses to a Recombinant Adenovirus Type 35 Tuberculosis Vaccine in Two Mouse Strains: CD4 and CD8 T-Cell Epitope Mapping and Role of Gamma Interferon

T. van der Poll, J. Sadoff, G. Weverling, 2007, Infection and Immunity.

Follicular dendritic cells and infection by human immunodeficiency virus type 1--a crucial target cell and virus reservoir.

J. G. van den Tweel, R. Broekhuizen, J. Goudsmit, 1995, Current topics in microbiology and immunology.

J. Goudsmit, F. de Wolf, J. van der Noordaa, 1987, British medical journal.

Protective Efficacy of a Single Immunization of a Chimeric Adenovirus Vector-Based Vaccine against Simian Immunodeficiency Virus Challenge in Rhesus Monkeys

S. Self, D. Montefiori, K. Mansfield, 2009, Journal of Virology.

Heterologous prime–boost vaccinations for poverty-related diseases: advantages and future prospects

A. Lemckert, K. Radošević, J. Goudsmit, 2009, Expert review of vaccines.

Magnitude and Phenotype of Cellular Immune Responses Elicited by Recombinant Adenovirus Vectors and Heterologous Prime-Boost Regimens in Rhesus Monkeys

K. Mansfield, M. Havenga, A. Lemckert, 2008, Journal of Virology.

Vascular endothelial growth factor levels in serum do not increase following HIV type 1 and HHV8 seroconversion and lack correlation with AIDS-related Kaposi's sarcoma.

T. Schulz, G. Weverling, J. Goudsmit, 2002, AIDS research and human retroviruses.

First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity.

S. Kostense, C. Rupprecht, G. Weverling, 2008, Vaccine.

Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.

G. Weverling, M. Zambon, K. Radošević, 2008, Vaccine.

Matrix-M Adjuvated Seasonal Virosomal Influenza Vaccine Induces Partial Protection in Mice and Ferrets against Avian H5 and H7 Challenge

F. Cox, K. Radošević, A. Roos, 2015, PloS one.

Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D

K. Mansfield, M. Havenga, A. Lemckert, 2007, Journal of Virology.

A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults.

J. Mascola, R. Koup, C. Andrews, 2010, Vaccine.

Suitability of PER.C6 cells to generate epidemic and pandemic influenza vaccine strains by reverse genetics.

M. Havenga, R. Vogels, W. Barclay, 2009, Vaccine.

The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries

C. Rupprecht, R. Kramer, J. de Kruif, 2005, European journal of immunology.

Risk factors for progression of human immunodeficiency virus (HIV) infection among seroconverted and seropositive homosexual men.

J. Goudsmit, F. de Wolf, M. Roos, 1990, American journal of epidemiology.

Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells.

M. Havenga, A. Lemckert, R. Vogels, 2006, The Journal of general virology.

ASSOCIATION BETWEEN BIOLOGICAL PROPERTIES OF HUMAN IMMUNODEFICIENCY VIRUS VARIANTS AND RISK FOR AIDS AND AIDS MORTALITY

J. Goudsmit, F. Wolf, R. Coutinho, 1989, The Lancet.

A recombinant Bacille Calmette-Guérin construct expressing the Plasmodium falciparum circumsporozoite protein enhances dendritic cell activation and primes for circumsporozoite-specific memory cells in BALB/c mice.

S. Kaufmann, K. Radošević, J. Goudsmit, 2012, Vaccine.

Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax.

J. Heeney, P. Krammer, J. Goudsmit, 1994, AIDS research and human retroviruses.

Host cell membrane proteins on human immunodeficiency virus type 1 after in vitro infection of H9 cells and blood mononuclear cells. An immuno-electron microscopic study.

P. Roholl, M. Sheikh, T. Meerloo, 1993, The Journal of general virology.

CD11a/CD 18 (LFA-1) Epitopes Involved in Syncytium Formation Among CD4+ T-Cells Following Cell Free HIV-1 Infection

J. Goudsmit, L. Smit, 1990 .

CD11a/CD18 (LFA-1) epitopes involved in syncytium formation among CD4+ T-cells following cell free HIV-1 infection.

J. Goudsmit, L. Smit, 1990, Viral immunology.

Antibodies to an HIV-1 synthetic peptide with partial homology to MULV P15E do not protect against AIDS.

A. Vahlne, J. Goudsmit, F. de Wolf, 1989, AIDS.

Maternal antibodies protect offspring from severe influenza infection and do not lead to detectable interference with subsequent offspring immunization

K. Radošević, R. Roozendaal, J. Vreugdenhil, 2017, Virology Journal.

Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells

F. Cox, K. Radošević, L. Dekking, 2015, PloS one.

A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity.

B. Landry, J. McClain, J. Sadoff, 2012, Vaccine.

Immunogenicity of Heterologous Recombinant Adenovirus Prime-Boost Vaccine Regimens Is Enhanced by Circumventing Vector Cross-Reactivity

M. Havenga, A. Lemckert, J. Goudsmit, 2006, Journal of Virology.

Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity.

B. Berkhout, P. Quax, M. Havenga, 2006, The Journal of general virology.

Immunogenicity of Recombinant Fiber-Chimeric Adenovirus Serotype 35 Vector-Based Vaccines in Mice and Rhesus Monkeys

K. Mansfield, M. Lifton, M. Havenga, 2005, Journal of Virology.

Neutralizing Antibodies to Adenovirus Serotype 5 Vaccine Vectors Are Directed Primarily against the Adenovirus Hexon Protein1

B. Walker, M. Addo, M. Lifton, 2005, The Journal of Immunology.

Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity1

S. Kostense, M. Lifton, N. Letvin, 2004, The Journal of Immunology.

Neutralizing Antibodies and CD8+ T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine Vectors

S. Kostense, M. Lifton, N. Letvin, 2004, Journal of Virology.

Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector

B. Berkhout, S. Kostense, G. Weverling, 2004, AIDS.

Clonal dominance: cause for a limited and failing immune response to HIV-1 infection and vaccination.

J. Goudsmit, P. Nara, H. Kohler, 1992, Journal of acquired immune deficiency syndromes.

Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity

S. Kostense, P. Quax, M. Havenga, 2003, Journal of Virology.

Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects.

J. Goudsmit, F. de Wolf, P. Cload, 1990, Antiviral research.

HIV heterogeneity and disease progression in AIDS: a model of continuous virus adaptation.

J. Goudsmit, V. Lukashov, 1998, AIDS.

Intra-blood-brain barrier synthesis of human immunodeficiency virus antigen and antibody in humans and chimpanzees.

L. Epstein, D. Gajdusek, G. Dawson, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Infectious Cellular Load in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals and Susceptibility of Peripheral Blood Mononuclear Cells from Their Exposed Partners to Non-Syncytium-Inducing HIV-1 as Major Determinants for HIV-1 Transmission in Homosexual Couples

H. Schuitemaker, N. Kootstra, J. Goudsmit, 1998, Journal of Virology.

See-ee: Clinical Characteristics of Highly Prevalent Seizure Disorders in the Gbawein and Wroughbarh Clan Region of Grand Bassa County, Liberia

D. Gajdusek, J. Goudsmit, F. V. D. Waals, 1983 .

The 200- and 150-kDa neurofilament proteins react with IgG autoantibodies from patients with kuru, Creutzfeldt-Jakob disease, and other neurologic diseases.

D. Gajdusek, J. Goudsmit, B. Toh, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Familial Alzheimer's disease in two kindreds of the same geographic and ethnic origin A clinical and genetic study

B. Keats, D. Gajdusek, J. Goudsmit, 1981, Journal of the Neurological Sciences.

Meeting the immense need for HAART in resource-poor settings.

J. Goudsmit, J. Bogaards, 2003, The Journal of antimicrobial chemotherapy.

Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN.

R. Koup, G. B. Karlsson Hedestam, M. Havenga, 2009, The Journal of general virology.

T-helper 1 cells elicited by H5N1 vaccination predict seroprotection.

R. Cox, A. Madhun, K. Hoschler, 2012, The Journal of infectious diseases.

Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam.

J. Goudsmit, R. Coutinho, R. Coutinho, 1988, AIDS.

Induction of CAMEL/NY-ESO-ORF2-specific CD8+ T cells upon stimulation with dendritic cells infected with a modified Ad5 vector expressing a chimeric Ad5/35 fiber

S. Kostense, M. Griffioen, M. Havenga, 2004, Cancer Gene Therapy.

Differential Antigen Requirements for Protection against Systemic and Intranasal Vaccinia Virus Challenges in Mice

J. Héraud, D. Kaufman, M. Havenga, 2008, Journal of Virology.

HIV-1 infection and virus production in follicular dendritic cells in lymph nodes. A case report, with analysis of isolated follicular dendritic cells.

J. Goudsmit, H. Schuurman, J. Borleffs, 1990, The American journal of pathology.

Detecting dinosaur DNA.

A. von Haeseler, J. Goudsmit, H. Zischler, 1995, Science.

Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine.

Martin H. Koldijk, G. Weverling, M. Havenga, 2007, Vaccine.

Distinct changes in HIV type 1 RNA versus p24 antigen levels in serum during short-term zidovudine therapy in asymptomatic individuals with and without progression to AIDS.

D. van Strijp, G. Weverling, J. Goudsmit, 1995, AIDS research and human retroviruses.

A sensitive cell-based assay for the detection of residual infectious West Nile virus.

S. Kostense, G. Weverling, J. Lewis, 2007, Vaccine.

The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils

J. Goudsmit, J. van der Noordaa, A. van Strien, 1982, Journal of medical virology.

Mutations within the CD4-CDR-3-like loop allow replication in an immortalized T cell line of HIV type 1 viruses chimeric for envelope glycoproteins containing non-syncytium-inducing V3 loops.

Q. Sattentau, J. Goudsmit, N. Signoret, 1997, AIDS research and human retroviruses.

Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

V. A. Stewart, J. Wittes, M. Thera, 2005, Vaccine.

The Th1 Immune Response to Plasmodium falciparum Circumsporozoite Protein Is Boosted by Adenovirus Vectors 35 and 26 with a Homologous Insert

R. Von Eyben, A. Lemckert, K. Radošević, 2010, Clinical and Vaccine Immunology.

Increased immunogenicity of recombinant Ad35-based malaria vaccine through formulation with aluminium phosphate adjuvant.

M. Havenga, K. Radošević, J. Goudsmit, 2007, Vaccine.

Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic human immunodeficiency virus-infected men.

P. Krijnen, E. Endert, J. Goudsmit, 1992, The Journal of infectious diseases.

Latent and lytic HHV‐8 mRNA expression in PBMCs and Kaposi's sarcoma skin biopsies of AIDS Kaposi's sarcoma patients

J. Goudsmit, M. Cornelissen, A. Polstra, 2003, Journal of medical virology.

Increased number of single‐LTR HIV‐1 DNA junctions correlates with HIV‐1 antigen expression and CD4+ cell decline in vivo

J. Goudsmit, M. Cornelissen, S. Jurriaans, 1995, Journal of medical virology.

Genetic immunization in the lung induces potent local and systemic immune responses

C. Andrews, G. Nabel, M. Roederer, 2010, Proceedings of the National Academy of Sciences.

Use of Dried Spots of Whole Blood, Plasma, and Mother's Milk Collected on Filter Paper for Measurement of Human Immunodeficiency Virus Type 1 Burden

W. Paxton, J. Goudsmit, R. Schuurman, 2007, Journal of Clinical Microbiology.

Measurement of HIV-1 Viral Burden Utilizing Dried Spots of Whole Blood , Plasma and Mother ’ s Milk Collected on Filter Paper

W. Paxton, J. Goudsmit, Georgios, 2007 .

Cytomegalovirus and human herpesvirus 8 DNA detection in peripheral blood monocytic cells of AIDS patients: Correlations with the presence of Kaposi's sarcoma and CMV disease

J. Goudsmit, M. Cornelissen, A. C. van der Kuyl, 2005, Journal of medical virology.

Retrospective, longitudinal analysis of serum human herpesvirus‐8 viral DNA load in AIDS‐related kaposi's sarcoma patients before and after diagnosis

J. Goudsmit, M. Cornelissen, A. C. van der Kuyl, 2004, Journal of medical virology.

Phylogenetic relationships among the species of the genus Testudo (Testudines: Testudinidae) inferred from mitochondrial 12S rRNA gene sequences.

J. Goudsmit, A. C. van der Kuyl, J. Dekker, 2002, Molecular phylogenetics and evolution.

Testudo ( Testudines : Testudinidae ) Inferred from Mitochondrial 12 S rRNA Gene Sequences

J. Goudsmit, J. Dekker, J. Maas, 2002 .

Timing of the HIV-1 subtype C epidemic in Ethiopia based on early virus strains and subsequent virus diversification

J. Goudsmit, V. Lukashov, G. Pollakis, 2001, AIDS.

Using phylogenetic analysis to trace HIV-1 migration among western European injecting drug users seroconverting from 1984 to 1997

R. Brettle, M. Prins, V. Schiffer, 2001, AIDS.

Subtype-specific sequence variation of the HIV type 1 long terminal repeat and primer-binding site.

B. Berkhout, J. Goudsmit, F. de Wolf, 2000, AIDS research and human retroviruses.

Peripheral blood mononuclear cells of HIV- and HCV-antibody-positive individuals contain HCV RNA but No HCV DNA despite evidence for reverse transcription of HIV RNA into DNA.

J. Goudsmit, M. Beld, M. Penning, 2000, Virology.

Simpliﬁed Strategy for Detection of Recombinant Human Immunodeﬁciency Virus Type 1 Group M Isolates by gag/env Heteroduplex Mobility Assay OF HIV EPIDEMICS IN AFRICAN

Groen, S. Coppens, J. Carr, 1999 .

Different Hepatitis C Virus (HCV) RNA Load Profiles Following Seroconversion among Injecting Drug Users without Correlation with HCV Genotype and Serum Alanine Aminotransferase Levels

J. Goudsmit, M. Beld, A. van den Hoek, 1998, Journal of Clinical Microbiology.

Aminotransferase Levels HCV Genotype and Serum Alanine Injecting Drug Users without Correlation with Profiles Following Seroconversion among Different Hepatitis C Virus ( HCV ) RNA Load

Van Den, J. Goudsmit, M. Beld, 1998 .

HIV type 1 subtype C in Addis Ababa, Ethiopia.

T. F. Rinke de Wit, C. Kuiken, J. Goudsmit, 1997, AIDS research and human retroviruses.

Consistent risk group-associated differences in human immunodeficiency virus type 1 vpr, vpu and V3 sequences despite independent evolution.

A. Gibbs, C. Kuiken, J. Goudsmit, 1996, The Journal of general virology.

Full-length proviruses of baboon endogenous virus (BaEV) and dispersed BaEV reverse transcriptase retroelements in the genome of baboon species

J. Goudsmit, A. C. van der Kuyl, J. Dekker, 1995, Journal of virology.

Virus load in chimpanzees infected with human immunodeficiency virus type 1: effect of pre-exposure vaccination.

M. Peeters, J. Heeney, H. Niphuis, 1995, The Journal of general virology.

Isolation of human immunodeficiency virus type 1 (HIV-1) RNA from feces by a simple method and difference between HIV-1 subpopulations in feces and serum

L. van der Hoek, J. Goudsmit, C. Sol, 1995, Journal of clinical microbiology.

Characterization of the specificity of the human antibody response to the V3 neutralization domain of HIV-1.

C. Kuiken, L. van der Hoek, J. Goudsmit, 1992, AIDS research and human retroviruses.

Natural HIV-1 NEF accelerates virus replication in primary human lymphocytes.

J. Goudsmit, W. Keulen, B. Klaver, 1992, Virology.

Failure of zidovudine prophylaxis after accidental exposure to HIV-1.

P. Reiss, C. Boucher, C. Hollak, 1990, The New England journal of medicine.

Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men.

J. Goudsmit, F. de Wolf, J. van der Noordaa, 1988, The Journal of infectious diseases.

Markers for progression to acquired immune deficiency syndrome and zidovudine treatment of asymptomatic patients.

J. Goudsmit, F. de Wolf, J. van der Noordaa, 1989, The Journal of infection.

RESUMPTION OF HIV ANTIGEN PRODUCTION DURING CONTINUOUS ZIDOVUDINE TREATMENT

P. Reiss, J. Goudsmit, C. Boucher, 1988, The Lancet.

EFFECT OF ZIDOVUDINE ON SERUM HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN LEVELS IN SYMPTOM-FREE SUBJECTS

J. Goudsmit, F. Wolf, P. Cload, 1988, The Lancet.

The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protection

Clarissa M Koch, Michael M. Desai, G. Alter, 2022, Frontiers in Virology.

Biological significance of the antibody response to HIV antigens expressed on the cell surface

E. Fenyö, J. Goudsmit, L. Smit, 2005, Archives of Virology.

Temporal development of cross-neutralization between HTLV-III B and HTLV-III RF in experimentally infected chimpanzees.

J. Goudsmit, C. Gibbs, L. Smit, 1988, Vaccine.

Induction in chimpanzees of antibodies inhibiting receptor-mediated cell fusion by HIV glycoprotein.

D. Gajdusek, J. Goudsmit, D. Asher, 1987, Viral immunology.

Improved Gene Delivery to Intestinal Mucosa by Adenoviral Vectors Bearing Subgroup B and D Fibers

O. Spiller, M. Havenga, A. Lemckert, 2006, Journal of Virology.

Human monoclonal antibodies for prophylaxis and therapy of viral infections

J. Goudsmit, J. Meulen, 2006, New Concepts of Antiviral Therapy.

Primary effect of chemotherapy on the transcription profile of AIDS-related Kaposi's sarcoma

C. V. van Noesel, J. Goudsmit, M. Cornelissen, 2002, BMC Cancer.

Overexpression of α-2,6-Sialyltransferase in PER.C6® cells leads to increased susceptibility for human influenza strains Submitted for publication

M. Havenga, R. Vogels, W. Barclay, 2010 .

An automated high-performance liquid chromatography procedure for the quantitation of L- and D-amino acids by means of stepwise precolumn derivatization.

A. Meijer, J. Goudsmit, F. V. van Hemert, 2001, Analytical biochemistry.

A Peptide-Based Plasmodium falciparum Circumsporozoite Assay To Test for Serum Antibody Responses to Pre-Erythrocyte Malaria Vaccines

S. Kostense, K. Radošević, J. Goudsmit, 2011, Clinical and Vaccine Immunology.

Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge

Joshua C. Johnson, R. Koup, N. Sullivan, 2011, Journal of Virology.

Impact of Recombinant Adenovirus Serotype 35 Priming versus Boosting of a Plasmodium falciparum Protein: Characterization of T- and B-Cell Responses to Liver-Stage Antigen 1

G. Weverling, M. Havenga, K. Radošević, 2008, Infection and Immunity.

Novel Replication-Incompetent Vector Derived from Adenovirus Type 11 (Ad11) for Vaccination and Gene Therapy: Low Seroprevalence and Non-Cross-Reactivity with Ad5

B. Berkhout, P. Quax, M. Havenga, 2004, Journal of Virology.

An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity.

S. Kostense, A. Osterhaus, A. Zakhartchouk, 2004, Vaccine.

Adenovirus fibre exchange alters cell tropism in vitro but not transgene-specific T CD8+ immune responses in vivo.

M. Havenga, A. Lemckert, J. Goudsmit, 2004, The Journal of general virology.

Decline in CD4+ cell numbers reflects increase in HIV-1 replication.

J. Goudsmit, F. de Wolf, J. van der Noordaa, 1988, AIDS research and human retroviruses.

Speed of progression to AIDS and degree of antibody response to accessory gene products of HIV‐1

C. Debouck, J. Goudsmit, F. de Wolf, 1990, Journal of medical virology.

Quantitative antibody responses to structural (core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: Impact of epitope variation and relationship to detection of HCV RNA in blood

J. Goudsmit, M. Beld, A. van den Hoek, 1999, Hepatology.

Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam.

J. Goudsmit, F. de Wolf, R. Coutinho, 1990, The Journal of infectious diseases.

Pre- and Postexposure Use of Human Monoclonal Antibody against H5N1 and H1N1 Influenza Virus in Mice: Viable Alternative to Oseltamivir

G. Weverling, M. Koldijk, J. Goudsmit, 2009, The Journal of infectious diseases.

Modulation of cell surface molecules during HIV‐1 infection of H9 cells. An immunoelectron microscopic study

A. Osterhaus, T. Meerloo, J. Goudsmit, 1992, AIDS.

Antibodies to HTLV‐I in populations of the southwestern Pacific

R. Garruto, J. Goudsmit, K. Pomeroy, 1988, Journal of medical virology.

Lymphoid follicles in cynomolgus monkeys after infection with simian immunodeficiency virus.

J. Tschopp, P. Biberfeld, T. Meerloo, 1993, Advances in experimental medicine and biology.

Appearance of predictors of disease progression in relation to the development of AIDS

J. Goudsmit, F. de Wolf, J. van der Noordaa, 1989, AIDS.

Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection.

G. Dawson, J. Goudsmit, J. Lange, 1987, The Journal of infectious diseases.

Low levels of specific T cell activation marker CD27 accompanied by elevated levels of markers for non-specific immune activation in the cerebrospinal fluid of patients with AIDS dementia complex

P. Portegies, R. Hintzen, T. Poll, 1993, Journal of Neuroimmunology.

Genotypic and Phenotypic Variation of HIV-1: Impact on AIDS Pathogenesis and Vaccination (Part 1 of 2)

J. Goudsmit, P. Nara, T. Wolfs, 1993 .

Genotypic and phenotypic variation of HIV-1: impact on AIDS pathogenesis and vaccination.

J. Goudsmit, P. Nara, T. Wolfs, 1993, Chemical immunology.

Ad5:Ad48 hexon hypervariable region substitutions lead to toxicity and increased inflammatory responses following intravenous delivery.

A. Parker, S. Nicklin, J. Custers, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

Age Dependence of Adenovirus-Specific Neutralizing Antibody Titers in Individuals from Sub-Saharan Africa

P. Jeena, G. Weverling, M. Havenga, 2006, Journal of Clinical Microbiology.

Spread of human T‐cell leukemia virus (HTLV‐I) in the Dutch homosexual community

J. Goudsmit, F. de Wolf, M. Bakker, 1987, Journal of medical virology.

International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations.

K. Mansfield, S. Buchbinder, M. Robb, 2011, Vaccine.

Greater and more rapid depletion of mitochondrial DNA in blood of patients treated with dual (zidovudine+didanosine or zidovudine+zalcitabine) vs. single (zidovudine) nucleoside reverse transcriptase inhibitors

P. Reiss, G. Weverling, J. Goudsmit, 2004, HIV medicine.

Extreme founder effect in an HIV type 1 subtype A epidemic among drug users in Svetlogorsk, Belarus.

J. Goudsmit, V. Lukashov, V. Eremin, 1998, AIDS research and human retroviruses.

Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection.

M. Zupancic, A. Haase, R. Mills, 1997, Science.

Novel Rabies Virus-Neutralizing Epitope Recognized by Human Monoclonal Antibody: Fine Mapping and Escape Mutant Analysis

C. Rupprecht, R. Kramer, J. de Kruif, 2005, Journal of Virology.

Circulation of HIV antigen in blood according to stage of infection, risk group, age and geographic origin

J. Goudsmit, D. Paul, 1987, Epidemiology and Infection.

Low AIDS Attack Rate Among Dutch Haemophiliacs Compared to Homosexual Men: A Correlate of HIV Antigenaemia Frequencies

J. Goudsmit, F. Wolf, M. Bakker, 1989, Vox sanguinis.

High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmission.

M. Kersten, D. Baarle, D. van Baarle, 2000, The Journal of infectious diseases.

HIV-Antibody Seroconversions in Dutch Haemophiliacs Using Heat-Treated and Non Heat-Treated Coagulation Factor Concentrates

J. Goudsmit, M. Bakker, L. Smit, 1988, Thrombosis and Haemostasis.

SEROCONVERSION TO HTLV-III IN HAEMOPHILIAC GIVEN HEAT-TREATED FACTOR VIII CONCENTRATE

J. Goudsmit, W. Berg, J. Cate, 1986, The Lancet.

Neurological and neuropathological features of human immunodeficiency virus infection in children

L. Epstein, J. Goudsmit, L. Sharer, 1988, Annals of neurology.

Evidence from the Baboon Catacomb in North Saqqara for a West Mediterranean Monkey Trade Route to Ptolemaic Alexandria *

J. Goudsmit, D. Brandon-Jones, 2000 .

Long-term survival of ancient DNA in Egypt: response to Zink and Nerlich (2003).

A. Cooper, M. Collins, I. Barnes, 2005, American journal of physical anthropology.

Changes in sexual behaviour and the fall in incidence of HIV infection among homosexual men.

J. Goudsmit, R. Coutinho, R. Coutinho, 1989, BMJ.

Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants

Jaap Goudsmit, Wolfgang Preiser, Johannes A Bogaards, 2006, PLoS medicine.

Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets

T. Kuiken, B. Haagmans, A. Osterhaus, 2004, The Lancet.

Specificity and function of the individual amino acids of an important determinant of human immunodeficiency virus type 1 that induces neutralizing activity.

R. Liskamp, R. Meloen, J. Goudsmit, 1989, The Journal of general virology.

Phosphate-methylated DNA aimed at HIV-1 RNA loops and integrated DNA inhibits viral infectivity.

H. Buck, L. Koole, J. Goudsmit, 1990, Science.

The paramount importance of serological surveys of SARS-CoV-2 infection and immunity

J. Goudsmit, 2020, European Journal of Epidemiology.

Twenty-seven-year time trends in dementia incidence in Europe and the United States

M. Fornage, A. Hofman, V. Gudnason, 2020, Neurology.

Human papovavirus isolated from urine of a child with acute tonsillitis.

J. Goudsmit, J. van der Noordaa, M. Baak, 1981, British medical journal.

Human immunodeficiency virus exanthem.

J. Goudsmit, J. Lange, H. Hulsebosch, 1990, Journal of the American Academy of Dermatology.

Antibodies to soluble CD4 in HIV-1-infected individuals.

J. Goudsmit, P. Schellekens, D. Zagury, 1988, AIDS.

Founder virus population related to route of virus transmission: a determinant of intrahost human immunodeficiency virus type 1 evolution?

J. Goudsmit, V. Lukashov, 1997, Journal of virology.

The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course?

D. van Strijp, H. Schuitemaker, G. Weverling, 1994, Virology.

Evaluation of adenoviral vectors

J. Goudsmit, A. Luty, O. Ophorst, 2008 .

Phylogeny of African monkeys based upon mitochondrial 12S rRNA sequences

C. Kuiken, J. Goudsmit, J. Dekker, 1995, Journal of Molecular Evolution.

Stabilizing formulations for inhalable powders of an adenovirus 35-vectored tuberculosis (TB) vaccine (AERAS-402).

Eric Tsao, Jaap Goudsmit, J. Sadoff, 2010, Vaccine.

EXPRESSION OF HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN (HIV-Ag) IN SERUM AND CEREBROSPINAL FLUID DURING ACUTE AND CHRONIC INFECTION

L. Epstein, H. Speelman, J. Goudsmit, 1986, The Lancet.

Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.

J. Goudsmit, F. de Wolf, S. Danner, 1986, British medical journal.

HTLV-III/LAV infection in nine children infected by a single plasma donor: clinical outcome and recognition patterns of viral proteins.

W. Kuis, J. Goudsmit, J. Lange, 1986, The Journal of infectious diseases.

Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus.

J. Goudsmit, S. Danner, L. Verdonck, 1986, British medical journal.

Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates

Lange, J. Goudsmit, F. de Wolf, 1989, Journal of virology.

Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs.

Jaap, F. Miedema, A. J. Petit, 1988, The Journal of clinical investigation.

Neutralization of HIV‐1: a paradox of humoral proportions

J. Goudsmit, P. Nara, R. Garrity, 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Expression and immunogenicity of the Plasmodium falciparum circumsporozoite protein: the role of GPI signal sequence.

M. Havenga, K. Radošević, J. Goudsmit, 2007, Vaccine.

Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys.

S. Santra, N. Letvin, J. Custers, 2009, Vaccine.

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

K. Mansfield, M. Lifton, M. Havenga, 2006, Nature.

Immunogenicity and Protection of a Recombinant Human Adenovirus Serotype 35-Based Malaria Vaccine against Plasmodium yoelii in Mice

B. Berkhout, M. Tsuji, M. Havenga, 2006, Infection and Immunity.

Immunogenicity of Heterologous Prime-Boost Regimens Involving Recombinant Adenovirus Serotype 11 (Ad11) and Ad35 Vaccine Vectors in the Presence of Anti-Ad5 Immunity

M. Lifton, M. Havenga, A. Lemckert, 2005, Journal of Virology.

Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development

J. de Kruif, J. Goudsmit, M. Throsby, 2007, Expert review of vaccines.

No predictive value of GC phenotypes for HIV infection and progression to AIDS

C. Boucher, R. Frants, A. Eriksson, 1988, Human Genetics.

Serum‐free transient protein production system based on adenoviral vector and PER.C6 technology: High yield and preserved bioactivity†

G. Hateboer, M. Havenga, R. Vogels, 2007, Biotechnology and bioengineering.

Quantitative Detection of Hepatitis B Virus DNA by Real-Time Nucleic Acid Sequence-Based Amplification with Molecular Beacon Detection

D. van Strijp, J. Goudsmit, B. van Gemen, 2001, Journal of Clinical Microbiology.

Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapy

B. Larder, C. Boucher, P. Kellam, 1990, The Lancet.

Inhibition of HIV-1 infectivity by phosphate-methylated DNA: retraction.

H. Buck, L. Koole, J. Goudsmit, 1990, Science.

A small-molecule fusion inhibitor of influenza virus is orally active in mice

I. Wilson, Divita Garg, D. Roymans, 2019, Science.

Hepatocellular carcinoma in Egyptians with and without a history of hepatitis B virus infection: association with hepatitis C virus (HCV) infection but not with (HCV) RNA level.

M. Hafez, J. Goudsmit, M. Beld, 1999, The American journal of tropical medicine and hygiene.

Decrease of HIV‐1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine

J. Leonard, N. Foudraine, J. Goudsmit, 1998, AIDS.

Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype

C. Kuiken, J. Goudsmit, W. Keulen, 1992, Journal of virology.

Detection of Human Immunodeficiency Virus Type 1 Nucleocapsid Protein p7 In Vitro and In Vivo

J. Goudsmit, F. de Wolf, K. van der Horn, 1999, Journal of Clinical Microbiology.

Detection of human immunodeficiency virus type 1 nucleocapsid protein p 7 in vitro and in vivo

Wolf, V. Der, J. Goudsmit, 1998 .

Immune response to HIV p24 core protein during the early phases of human immunodeficiency virus infection.

M. Ascher, H. Sheppard, J. Goudsmit, 1991, AIDS research and human retroviruses.

Preliminary findings of an in vitro human spleen mononuclear cell culture system for primary isolates of HIV type 1.

H. Kung, J. Goudsmit, P. Nara, 1997, AIDS research and human retroviruses.

Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4+ cell counts.

F. Miedema, J. D. de Wit, I. Keet, 1994, The Journal of infectious diseases.

C. Kuiken, P. Van de Perre, J. Goudsmit, 1995, Journal of virology.

Human CD46-transgenic mice in studies involving replication-incompetent adenoviral type 35 vectors.

P. Quax, G. Weverling, M. Havenga, 2006, The Journal of general virology.

TransferAdenovirus Serotype 5 Gene Effect of Neutralizing Sera on Factor

M. Havenga, J. Custers, J. Goudsmit, 2014 .

Effect of Neutralizing Sera on Factor X-Mediated Adenovirus Serotype 5 Gene Transfer

N. Van Rooijen, M. Havenga, A. Parker, 2008, Journal of Virology.

Quantifying Adenovirus-Neutralizing Antibodies by Luciferase Transgene Detection: Addressing Preexisting Immunity to Vaccine and Gene Therapy Vectors

Jaap Goudsmit, Stefan Kostense, S. Kostense, 2003, Journal of Clinical Microbiology.

Viral Replication Under Combination Antiretroviral Therapy: A Comparison of Four Different Regimens

C. Fraser, A. Ghani, C. Donnelly, 2002, Journal of acquired immune deficiency syndromes.

Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy.

P. Portegies, J. Goudsmit, S. Danner, 2000 .

Evolution of human immunodeficiency virus subtype A in women seroconverting post partum and in their offspring post-natally infected by ingestion of breast milk.

E. Karita, C. Kuiken, J. Goudsmit, 1997, The Journal of general virology.

Primary infections with HIV-1 of women and their offspring in Rwanda: findings of heterogeneity at seroconversion, coinfection, and recombinants of HIV-1 subtypes A and C.

E. Karita, J. Goudsmit, P. Msellati, 1997, Virology.

Development of real-time NASBA assays with molecular beacon detection to quantify mRNA coding for HHV-8 lytic and latent genes

J. Goudsmit, M. Cornelissen, A. Polstra, 2002, BMC infectious diseases.

Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): analysis of seroconversions to ORF65 and ORF73.

S. Heisterkamp, T. Schulz, G. Weverling, 2000, Proceedings of the National Academy of Sciences of the United States of America.

EBV infection is linked to a fatal B-cell proliferation in young males with X-linked lymphoproliferative disease , posttransplant lymphomas , immunoblastic lymphomas in AIDS patients

T. Schulz, J. Goudsmit, N. Renwick, 2000 .

Favourable Effect of Chemotherapy on Clinical Symptoms and Human Herpesvirus-8 DNA Load in a Patient with Kaposi's Sarcoma Presenting with Fever and Anemia

P. Reiss, J. Veenstra, J. Goudsmit, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

The Human Antibody Response Against WNV

J. Goudsmit, M. Throsby, J. Kruif, 2009, West Nile Encephalitis Virus Infection.

Nuclear counterparts of the cytoplasmic mitochondrial 12S rRNA gene: A problem of ancient DNA and molecular phylogenies

C. Kuiken, J. Goudsmit, W. Perizonius, 1995, Journal of Molecular Evolution.

Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays

B. Walker, J. Mullins, E. Delwart, 1994, Journal of virology.

T Cell Telomere Length in HIV-1 Infection: No Evidence for Increased CD4+ T Cell Turnover

Niels Schaft, Jaap Goudsmit, Frank de Wolf, 1996, Science.

Myeloid and Plasmacytoid Dendritic Cells Are Susceptible to Recombinant Adenovirus Vectors and Stimulate Polyfunctional Memory T Cell Responses

R. Koup, M. Havenga, J. Goudsmit, 2007, The Journal of Immunology.

Detection and Characterization of HIV‐1 By Polymerase Chain Reaction

J. Sninsky, J. Goudsmit, W. Krone, 1990, Journal of acquired immune deficiency syndromes.

Immune correlates of protection from HIV infection and AIDS.

S. Zolla-Pazner, J. Heeney, L. Montagnier, 1997, Immunology today.

Cytochemical analysis of human T cell leukaemia virus I LTR-regulated beta-galactosidase gene expression using a novel integrated cell system.

J. Heeney, J. Goudsmit, D. Derse, 1993, Journal of virological methods.

Analysis of human immunodeficiency virus type 1 LTR-LTR junctions in peripheral blood mononuclear cells of infected individuals.

J. Goudsmit, M. Cornelissen, S. Jurriaans, 1992, The Journal of general virology.

Novel Endogenous Type C Retrovirus in Baboons: Complete Sequence, Providing Evidence for Baboon Endogenous Virusgag-pol Ancestry

J. Goudsmit, A. C. van der Kuyl, R. Mang, 1999, Journal of Virology.

Biological age in healthy elderly predicts aging-related diseases including dementia

A. Hofman, M. Ikram, M. Ghanbari, 2021, Scientific Reports.

Apelin, the Natural Ligand of the Orphan Seven-Transmembrane Receptor APJ, Inhibits Human Immunodeficiency Virus Type 1 Entry

J. Sodroski, O. Nishimura, S. Hinuma, 2000, Journal of Virology.

High-level expression from two independent expression cassettes in replication-incompetent adenovirus type 35 vector.

M. Havenga, R. Vogels, K. Radošević, 2007, The Journal of general virology.

First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001).

Jennifer A. Johnson, J. Goudsmit, D. Barouch, 2013, The Journal of infectious diseases.

pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D

Remco, J. Goudsmit, M. Cornelissen, 1997, Journal of virology.

Molecular and Biological Characterization of Human Monoclonal Antibodies Binding to the Spike and Nucleocapsid Proteins of Severe Acute Respiratory Syndrome Coronavirus

H. Doerr, A. Osterhaus, W. Preiser, 2005, Journal of Virology.

Heat-shock induction of the human immunodeficiency virus long terminal repeat.

J. Goudsmit, J. Geelen, R. Minnaar, 1988, The Journal of general virology.

Association between CCR5 Genotype and the Clinical Course of HIV-1 Infection

H. Schuitemaker, I. Keet, M. Prins, 1997, Annals of Internal Medicine.

A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis.

C. Rupprecht, R. Kramer, J. de Kruif, 2007, Annual review of medicine.

HIV infection and STD in drug addicted prostitutes in Amsterdam: potential for heterosexual HIV transmission.

J. Goudsmit, R. Coutinho, H. V. van Haastrecht, 1989, Genitourinary medicine.

Silent mutation pattern in V3 sequences distinguishes virus according to risk group in Europe.

C. Kuiken, J. Goudsmit, 1994, AIDS research and human retroviruses.

Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization.

Characterization, E. Karita, C. Kuiken, 1994, AIDS research and human retroviruses.

Characterization of murine monoclonal antibodies to the tat protein from human immunodeficiency virus type 1

C. Debouck, R. Meloen, J. Goudsmit, 1990, Journal of virology.

Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid, and continuous.

J. Goudsmit, H. van den Berg, T. Wolfs, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Xenotransplantation: about baboon hearts and pig livers.

J. Goudsmit, A. C. van der Kuyl, 1998, Trends in microbiology.

Determination of Aneurin (= Vitamin B1) in Urine by the Thiochrome Method

J. Goudsmit, H. G. K. WESTENBRINK, 1937, Nature.

Comparison and fine mapping of both high and low neutralizing monoclonal antibodies against the principal neutralization domain of HIV-1

R. Meloen, J. Goudsmit, J. Langedijk, 2005, Archives of Virology.

Neutralizing activity of anti-peptide antibodies against the principal neutralization domain of human immunodeficiency virus type 1.

R. Meloen, J. Goudsmit, J. Langedijk, 1991, The Journal of general virology.

HIV-1 P24 antigenaemia does not predict time of survival in AIDS patients.

P. Reiss, P. Krijnen, J. Goudsmit, 1990, Genitourinary medicine.

Evolutionary Relationships among Parvoviruses: Virus-Host Coevolution among Autonomous Primate Parvoviruses and Links between Adeno-Associated and Avian Parvoviruses

J. Goudsmit, V. Lukashov, 2001, Journal of Virology.

Development and deployment of COVID-19 vaccines for those most vulnerable

R. Baric, G. Neumann, Y. Kawaoka, 2021, Science Translational Medicine.

Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin.

C. Hanlon, C. Rupprecht, M. Niezgoda, 2006, The Journal of infectious diseases.

Novel Human Monoclonal Antibody Combination Effectively Neutralizing Natural Rabies Virus Variants and Individual In Vitro Escape Mutants

Jaap Goudsmit, C. Hanlon, C. Rupprecht, 2005, Journal of Virology.

Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution

J. Goudsmit, W. Keulen, J Goudsmit, 1992, Journal of virology.

Genomic human immunodeficiency virus type 1 RNA variation in mother and child following intra-uterine virus transmission.

C. Kuiken, J. Goudsmit, J. Dekker, 1993, The Journal of general virology.

Hepatitis C Virus Serotype-Specific Core and NS4 Antibodies in Injecting Drug Users Participating in the Amsterdam Cohort Studies

J. Goudsmit, M. Beld, A. van den Hoek, 1998, Journal of Clinical Microbiology.

Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period

C. Kuiken, J. Goudsmit, V. Lukashov, 1995, Journal of virology.

Priorities in AIDS Diagnostics in the 1990s: Towards the Monitoring of Virus Replication

J. Goudsmit, 1991 .

Establishment of New Transmissible and Drug-Sensitive Human Immunodeficiency Virus Type 1 Wild Types due to Transmission of Nucleoside Analogue-Resistant Virus

R. D. de Boer, L. van der Hoek, M. V. van Dooren, 2001, Journal of Virology.

Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase

A S Perelson, A. Perelson, D. Ho, 1996, Journal of virology.

UvA-DARE ( Digital Academic Repository ) Broad spectrum of in vivo fitness of human immunodeficiency virus type I subpopulations differing at reverse transcriptase codons 41 and 215

J. Goudsmit, A. D. Ronde, E. D. Rooij, 2017 .

Plasma HIV-1 RNA to Guide Patient Selection for Antiretroviral Therapy in Resource-Poor Settings: Efficiency Related to Active Case Finding

A. Zwinderman, P. Bossuyt, G. Weverling, 2006, Journal of acquired immune deficiency syndromes.

Identification of Sequential Viral Escape Mutants Associated with Altered T-Cell Responses in a Human Immunodeficiency Virus Type 1-Infected Individual

Marion Cornelissen, Jaap Goudsmit, Hanneke Schuitemaker, 2003, Journal of Virology.

AIDS vaccines that allow HIV-1 to infect and escape immunologic control: a mathematic analysis of mass vaccination.

M. Boerlijst, G. Weverling, J. Goudsmit, 2003, Journal of acquired immune deficiency syndromes.

Primary HIV‐1 Subtype C Infection in Ethiopia

F. Miedema, R. Geskus, J. Goudsmit, 2002, Journal of acquired immune deficiency syndromes.

Naturally HIV-1 seroconverters with lowest viral load have best prognosis, but in time lose control of viraemia.

H. Schuitemaker, G. Weverling, J. Goudsmit, 2002, AIDS.

The genetic diversity of HIV-1 and its implications for vaccine development

W. Paxton, J. Goudsmit, V. Lukashov, 2002 .

One-Tube Real-Time Isothermal Amplification Assay To Identify and Distinguish Human Immunodeficiency Virus Type 1 Subtypes A, B, and C and Circulating Recombinant Forms AE and AG

Jaap Goudsmit, E. Timmermans, J. Goudsmit, 2001, Journal of Clinical Microbiology.

Single Rapid Real-Time Monitored Isothermal RNA Amplification Assay for Quantification of Human Immunodeficiency Virus Type 1 Isolates from Groups M, N, and O

M. V. van Dooren, J. Goudsmit, B. van Gemen, 2001, Journal of Clinical Microbiology.

Intrahost Selective Pressure and HIV-1 Heterogeneity During Progression to AIDS

J. Goudsmit, V. Lukashov, 2001 .

Slower decline of plasma HIV-1 RNA following highly suppressive antiretroviral therapy in primary compared with chronic infection

Roy M. Anderson, Hein Putter, Neil M. Ferguson, 2000, AIDS.

Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptations.

D. Mcclernon, J. Goudsmit, F. de Wolf, 2000, AIDS research and human retroviruses.

Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo.

J. Goudsmit, R. Colebunders, L. Kestens, 2000, AIDS research and human retroviruses.

Specific passage of simian immunodeficiency virus from end-stage disease results in accelerated progression to AIDS in rhesus macaques.

J. Heeney, H. Niphuis, J. Goudsmit, 1999, The Journal of general virology.

Design and Evaluation of a Human Immunodeficiency Virus Type 1 RNA Assay Using Nucleic Acid Sequence-Based Amplification Technology Able To Quantify Both Group M and O Viruses by Using the Long Terminal Repeat as Target

J. Goudsmit, F. de Wolf, P. Oudshoorn, 1999, Journal of Clinical Microbiology.

Design and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as target de Baar,

Wolf, Frank, Anthony, 1999 .

Rate of HIV‐1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen

A S Perelson, A. Perelson, J. Mittler, 1998, AIDS.

Temporal relationship between human immunodeficiency virus type 1 RNA levels in serum and cellular infectious load in peripheral blood.

H. Schuitemaker, A. B. van 't Wout, J. Goudsmit, 1997, The Journal of infectious diseases.

Longitudinal analysis of CD4 T cell counts, T cell reactivity, and human immunodeficiency virus type 1 RNA levels in persons remaining AIDS-free despite CD4 cell counts <200 for >5 years.

I P Keet, F Miedema, M R Klein, 1997, The Journal of infectious diseases.

Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215

R de Boer, R. de Boer, J. Goudsmit, 1997, Journal of virology.

Ad35 and Ad26 Vaccine Vectors Induce Potent and Cross-Reactive Antibody and T-Cell Responses to Multiple Filovirus Species

H. Schuitemaker, G. Weverling, J. Custers, 2012, PloS one.

Vector Choice Determines Immunogenicity and Potency of Genetic Vaccines against Angola Marburg Virus in Nonhuman Primates

R. Koup, N. Sullivan, P. Jahrling, 2010, Journal of Virology.

A monocyte chemotaxis inhibiting factor in serum of HIV infected men shares epitopes with the HIV transmembrane protein gp41.

H. Drexhage, J. Goudsmit, M. Tas, 1988, Clinical and experimental immunology.

Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001).

U. Reimer, H. Wenschuh, N. Frahm, 2013, The Journal of infectious diseases.

Characterization of HIV‐1 neutralization escape mutants

L. Pearl, R. Weiss, J. McKeating, 1989, AIDS.

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.

C. Debouck, D. Gajdusek, R. Meloen, 1988, Proceedings of the National Academy of Sciences of the United States of America.

EVALUATION OF SIX ENZYME IMMUNOASSAYS FOR ANTIBODY AGAINST HUMAN IMMUNODEFICIENCY VIRUS

J Desmyter, C. Aaij, H. Reesink, 1986, The Lancet.

RNA Detection and Subtype C Assessment of HIV-1 in Infants with Diarrhea in Ethiopia

B. Berkhout, W. Paxton, J. Goudsmit, 2009, The open AIDS journal.

Competing Interests: GJN:

R. Koup, N. Sullivan, P. Jahrling, 2022 .

PER.C6(®) cells as a serum-free suspension cell platform for the production of high titer poliovirus: a potential low cost of goods option for world supply of inactivated poliovirus vaccine.

H. Schuitemaker, V. Klaren, J. Custers, 2013, Vaccine.

Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer.

D. Bhella, N. Van Rooijen, A. Parker, 2009, Blood.

Intradermal Delivery of Adenoviral Type-35 Vectors Leads to High Efficiency Transduction of Mature, CD8+ T Cell-Stimulating Skin-Emigrated Dendritic Cells

T. D. de Gruijl, M. Havenga, K. Radošević, 2006, The Journal of Immunology.

HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS.

T. F. Rinke de Wit, H. Schuitemaker, C. Kuiken, 1999, AIDS.

Antigenic diversity thresholds and the development of AIDS.

M A Nowak, R M May, M. Nowak, 1991, Science.

Evidence for HIV type 1 strains of U.S. intravenous drug users as founders of AIDS epidemic among intravenous drug users in northern Europe.

D. Vlahov, C. Kuiken, J. Goudsmit, 1996, AIDS research and human retroviruses.

Conserved V3 loop sequences and transmission of human immunodeficiency virus type 1.

E. G. Shpaer, J. Mullins, E. Delwart, 1994, AIDS research and human retroviruses.

HIV-1 genomic RNA diversification following sexual and parenteral virus transmission.

J. Goudsmit, G. Zwart, M. Bakker, 1992, Virology.

Immunodominance and antigenic variation of the principal neutralization domain of HIV-1.

L. van der Hoek, J. Goudsmit, G. Zwart, 1991, Virology.

Validation of the Rapid Fluorescent Focus Inhibition Test for Rabies Virus-Neutralizing Antibodies in Clinical Samples

S. Kostense, C. Hanlon, G. Weverling, 2012, Antimicrobial Agents and Chemotherapy.

The potential of targeted antibody prophylaxis in SARS outbreak control: A mathematic analysis☆

H. Putter, J. Goudsmit, J. T. ter Meulen, 2006, Travel Medicine and Infectious Disease.

CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individuals.

Jaap Goudsmit, Hanneke Schuitemaker, Georgios Pollakis, 2006, Virology.

Broad Cross-Clade T-Cell Responses to Gag in Individuals Infected with Human Immunodeficiency Virus Type 1 Non-B Clades (A to G): Importance of HLA Anchor Residue Conservation

W. Paxton, J. Shiver, J. Goudsmit, 2005, Journal of Virology.

Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.

C. Herzog, J. Goudsmit, R. Kompier, 2009, Vaccine.

Highly Conserved Protective Epitopes on Influenza B Viruses

N. S. Laursen, L. Poon, I. Wilson, 2012, Science.

New Class of Monoclonal Antibodies against Severe Influenza: Prophylactic and Therapeutic Efficacy in Ferrets

Martin H. Koldijk, A. Osterhaus, P. Lenting, 2010, PloS one.

Genetic differences between human immunodeficiency virus type 1 subpopulations in faeces and serum.

C. Kuiken, L. van der Hoek, J. Goudsmit, 1998, The Journal of general virology.

Human immunodeficiency virus type 1 RNA populations in faeces with higher homology to intestinal populations than to blood populations.

J. Bartelsman, L. van der Hoek, J. Goudsmit, 1996, The Journal of general virology.

Recombination of HIV type 1C (C'/C") in Ethiopia: possible link of EthHIV-1C' to subtype C sequences from the high-prevalence epidemics in India and Southern Africa.

Marion Cornelissen, Jaap Goudsmit, Girma Tesfaye, 2003, AIDS research and human retroviruses.

Diverse patterns of recognition of hepatitis C virus core and nonstructural antigens by antibodies present in Egyptian cancer patients and blood donors

A. Zekri, J. Goudsmit, F. de Wolf, 1996, Journal of clinical microbiology.

Circulation of subtype A and gagA/envB recombinant HIV type 1 strains among injecting drug users in St. Petersburg, Russia, correlates with geographical origin of infections.

J. Goudsmit, V. Lukashov, J Goudsmit, 1999, AIDS research and human retroviruses.

Simultaneous introduction of distinct HIV‐1 subtypes into different risk groups in Russia, Byelorussia and Lithuania

J. Goudsmit, F. Wolf, M. Cornelissen, 1995, AIDS.

Declining incidence of AIDS dementia complex after introduction of zidovudine treatment.

P. Portegies, H. Speelman, J. Goudsmit, 1989, BMJ.

Is population-level perversity a likely outcome of mass vaccination against HIV?

M. Boerlijst, J. Goudsmit, W. M. van Ballegooijen, 2005, The Lancet. Infectious diseases.

Fluctuations in steady state level of genomic HIV-1 RNA and replication intermediates related to disease progression rate.

J. Goudsmit, S. Jurriaans, 1996, Immunology letters.

Lymphoproliferative response to HIV type 1 p24 in long-term survivors of HIV type 1 infection is predictive of persistent AIDS-free infection.

I. Keet, J. Goudsmit, M. Roos, 1999, AIDS research and human retroviruses.

Development of a Nucleic Acid Sequence-Based Amplification Assay That Uses gag-Based Molecular Beacons To Distinguish between Human Immunodeficiency Virus Type 1 Subtype C and C′ Infections in Ethiopia

J. Goudsmit, B. van Gemen, Wendelien Dorigo-Zetsma, 2004, Journal of Clinical Microbiology.

Risk factors and prevalence of HIV antibodies in homosexual men in the Netherlands.

J. Goudsmit, F. de Wolf, J. van der Noordaa, 1987, American journal of epidemiology.

Evolutionary relationships among Astroviridae.

J. Goudsmit, V. Lukashov, 2002, The Journal of general virology.

Low levels of hepatitis C virus RNA in serum, plasma, and peripheral blood mononuclear cells of injecting drug users during long antibody-undetectable periods before seroconversion.

J. Goudsmit, M. Beld, M. Damen, 1999, Blood.

Human immunodeficiency virus type 1 antigen in cerebrospinal fluid. Correlation with clinical neurologic status.

L. Epstein, P. Portegies, J. Goudsmit, 1989, Archives of neurology.

Influenza-like syndrome in homosexual men: a prospective diagnostic study.

C. Hooykaas, J. Goudsmit, F. de Wolf, 1988, The Journal of the Royal College of General Practitioners.

Intrathecal synthesis of antibodies to HTLV-III in patients without AIDS or AIDS related complex.

E. Wolters, J. Goudsmit, M. Bakker, 1986, British medical journal.

Gross defects in the vpr and vpu genes of HIV type 1 cannot explain the differences in RNA copy number between long-term asymptomatics and progressors.

C. Kuiken, J. Goudsmit, M. Cornelissen, 1997, AIDS research and human retroviruses.

Human antibody response to a strain-specific HIV-1 gp120 epitope associated with cell fusion inhibition.

C. Boucher, L. Epstein, L. van der Hoek, 1988, AIDS.

Challenges in the Search for an HIV Vaccine

A. Lemckert, J. Goudsmit, D. Barouch, 2003, European Journal of Epidemiology.

Human Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment Step

T. Pierson, M. Diamond, S. Austin, 2009, Journal of Virology.

Simplified Strategy for Detection of Recombinant Human Immunodeficiency Virus Type 1 Group M Isolates bygag/env Heteroduplex Mobility Assay

S. Coppens, J. Carr, M. Salminen, 2000, Journal of Virology.

Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. Study Group on Heterogeneity of HIV Epidemics in African Cities.

S. Coppens, J. Carr, M. Salminen, 2000, Journal of virology.

Timing of the introduction into Ethiopia of subcluster C' of HIV type 1 subtype C.

T. F. Rinke de Wit, J. Goudsmit, V. Lukashov, 2001, AIDS research and human retroviruses.

Neurologic manifestations of human immunodeficiency virus infection in children.

L. Epstein, M. Robert-Guroff, J. Goudsmit, 1986, Pediatrics.

Analysis of the antigen- and mitogen-induced differentiation of B lymphocytes from asymptomatic human immunodeficiency virus-seropositive male homosexuals. Discrepancy between T cell-dependent and T cell-independent activation.

A. Osterhaus, T. Logtenberg, J. Goudsmit, 1987, Journal of immunology.

Malnutrition and concomitant herpesvirus infection as a possible cause of immunodeficiency syndrome in Haitian infants.

J. Goudsmit, 1983, The New England journal of medicine.

AIDS dementia complex and didanosine

P. Reiss, P. Portegies, J. Goudsmit, 1994, The Lancet.

Impact of HIV antibody testing on changes in sexual behavior among homosexual men in The Netherlands.

J. Goudsmit, F. de Wolf, J. van der Noordaa, 1988, American journal of public health.

Human herpesvirus 8 infections in the Amsterdam Cohort Studies ( 1984 – 1997 ) : Analysis of seroconversions to ORF 65 and ORF 73

S. Heisterkamp, T. Schulz, G. Weverling, 2000 .

HlV-Antibody Seroconversions in Dutch Haemophiliacs Using Heat-Treated and Non Heat-Treated Goagulation Factor Concentrates

J. Goudsmit, F., M. Bakker, 2018 .

Humoral immune responses in human HIV-1 infection clearance of initial burst of virus replication and protection against disease progression.

J. Goudsmit, 1992, International reviews of immunology.

DECLINE OF ANTIBODY REACTIVITY TO HIV CORE PROTEIN SECONDARY TO INCREASED PRODUCTION OF HIV ANTIGEN

J. Goudsmit, J. Lange, 1987, The Lancet.

The natural history of HIV infection in homosexual men

J. Goudsmit, F. Wolf, R. Coutinho, 1987 .

Immunodominant B-cell epitopes of the HIV-1 envelope recognized by infected and immunized hosts.

J. Goudsmit, 1988, AIDS (London).

Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects.

B. Larder, C. Boucher, P. Kellam, 1992, The Journal of infectious diseases.

Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains

M. Boerlijst, L. van der Hoek, G. Weverling, 2001, AIDS.

Gene Diversity of Five Human Immunodeficiency Virus Type 1 Subtypes : Evidence for Naturally Occurring Mutations That Contribute to Drug Resistance , Limited Recombination Patterns , and Common Ancestry for Subtypes B and D

Remco, Van Den, J. Goudsmit, 1997 .

Naturally occurring antibodies isolated from PD patients inhibit synuclein seeding in vitro and recognize Lewy pathology

J. Hoozemans, J. Goudsmit, W. Koudstaal, 2019, Acta Neuropathologica.

Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline.

J. Goudsmit, F. de Wolf, S. Danner, 1987, AIDS.

Pathogenesis of HIV and its implications for serodiagnosis and monitoring of antiviral therapy.

L. Epstein, J. Goudsmit, S. Danner, 1987, Journal of virological methods.

EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium.

Q. Sattentau, S. McCormack, G. Pantaleo, 2008, Vaccine.

Vaccine Protection Against Acquisition of Neutralization-Resistant SIV Challenges in Rhesus Monkeys

Jerome H. Kim, H. Schuitemaker, D. Stablein, 2011, Nature.

Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses.

J. Goudsmit, S. Danner, J. Cremers, 2001, AIDS research and human retroviruses.

Serological markers in HIV infection.

J. Goudsmit, F. de Wolf, J. van der Noordaa, 1988, Annales de medecine interne.

Efficacy of the Latest Generation of Antibody Assays for (Early) Detection of HIV 1 and HIV 2 Infection

C. Boucher, H. Reesink, J. Goudsmit, 1989, Vox sanguinis.

Natural variants of the HIV-1 long terminal repeat: analysis of promoters with duplicated DNA regulatory motifs.

B. Berkhout, J. Goudsmit, J. Geelen, 1992, Virology.

Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals.

C. Debouck, P. Reiss, C. Kuiken, 1991, Journal of acquired immune deficiency syndromes.

Immune age and biological age as determinants of vaccine responsiveness among elderly populations: the Human Immunomics Initiative research program

W. Koff, G. Alter, J. Goudsmit, 2021, European Journal of Epidemiology.

OKT3 and IL-2 Treatment for Purging of the Latent HIV-1 Reservoir in Vivo Results in Selective Long-Lasting CD4+ T Cell Depletion

H. Schuitemaker, C. Fox, A. Eerenberg, 2001, Journal of Clinical Immunology.

AFRICAN SWINE FEVER VIRUS ANTIBODY NOT FOUND IN AIDS PATIENTS

N. Clumeck, J. Goudsmit, J. Colaert, 1983, The Lancet.

Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells

Y. Guan, L. Poon, M. Peiris, 2008, PloS one.

Viral gene expression, antibody production and immune complex formation in human immunodeficiency virus infection.

J. Goudsmit, F. de Wolf, R. Coutinho, 1987, AIDS.

Evidefice for and against the transmissibility of Alzheimer

C. Masters, D. Gajdusek, J. Goudsmit, 2010 .

C-Type Lectin-Like Molecule-1

G. Schuurhuis, G. Ossenkoppele, Judith A. Bia, 2004, Cancer Research.

Human Monoclonal Antibodies for Prophylaxis and Treatment of Influenza

J. Goudsmit, W. Koudstaal, R. Friesen, 2011 .

Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: a novel RP-HPLC method.

J. C. Kapteyn, G. Weverling, J. Goudsmit, 2006, Vaccine.

Phenotypic and Genotypic Comparisons of CCR5- and CXCR4-Tropic Human Immunodeficiency Virus Type 1 Biological Clones Isolated from Subtype C-Infected Individuals

H. Schuitemaker, W. Paxton, J. Goudsmit, 2004, Journal of Virology.

Identification of a genetic subcluster of HIV type 1 subtype C (C') widespread in Ethiopia.

T. F. Rinke de Wit, J. Goudsmit, M. Cornelissen, 2000, AIDS research and human retroviruses.

Distribution of baboon endogenous virus among species of African monkeys suggests multiple ancient cross-species transmissions in shared habitats

J. Goudsmit, A. C. van der Kuyl, J. Dekker, 1995, Journal of virology.

Should assays drive science or vice versa?

J. Goudsmit, M. Johnston, 1997, The Lancet.

Structural Basis for Recognition of a Unique Epitope by a Human Anti-tau Antibody.

I. Wilson, J. Hoozemans, J. Wadia, 2018, Structure.

Antibody response to human immunodeficiency virus type 1 protease according to risk group and disease stage

C. Debouck, C. Boucher, L. Epstein, 1989, Journal of clinical microbiology.

Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates

S. Santra, M. Lifton, N. Letvin, 2012, Vaccine.

Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study

Albert Hofman, Silvan Licher, Reem Waziry, 2020, Brain : a journal of neurology.

Lack of correlation between V3‐loop peptide enzyme immunoassay serologic subtyping and genetic sequencing

J. Goudsmit, L. Heyndrickx, J. Nkengasong, 1998, AIDS.

Greater diversity of the HIV-1 V3 neutralization domain in Tanzania compared with The Netherlands: serological and genetic analysis.

C. Kuiken, C. Boucher, J. Goudsmit, 1993, AIDS.

Recent Evolutionary History of Human Immunodeficiency Virus Type 1 Subtype B: Reconstruction of Epidemic Onset Based on Sequence Distances to the Common Ancestor

Jaap Goudsmit, J. Goudsmit, V. Lukashov, 2002, Journal of Molecular Evolution.

Evolution of the human immunodeficiency virus type 1 subtype-specific V3 domain is confined to a sequence space with a fixed distance to the subtype consensus

J. Goudsmit, V. Lukashov, 1997, Journal of virology.

Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes. The UNAIDS Network for HIV Isolation and Characterization

J. Goudsmit, M. Cornelissen, F. Zorgdrager, 1996, Journal of virology.

Calcium-mediated inhibition of phorbol ester and Tax trans-activation of the human T cell leukaemia virus type 1.

J. Heeney, J. Goudsmit, K. Copeland, 1994, The Journal of general virology.

Selection by AZT and rapid replacement in the absence of drugs of HIV type 1 resistant to multiple nucleoside analogs.

R. D. de Boer, J. Goudsmit, S. Danner, 2001, AIDS research and human retroviruses.

Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs.

M. Hillebrand, J. Goudsmit, F. de Wolf, 1999, AIDS.

Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease

J. Goudsmit, C. Hadjichrysanthou, F. de Wolf, 2017, European Journal of Epidemiology.

Affinity ranking of antibodies using flow cytometry: application in antibody phage display-based target discovery.

Jaap Goudsmit, F. Cox, J. de Kruif, 2005, Journal of immunological methods.

Effect of human immunodeficiency virus (HIV) antibody knowledge on high-risk sexual behavior with steady and nonsteady sexual partners among homosexual men.

E M de Vroome, G J van Griensven, J. Goudsmit, 1989, American journal of epidemiology.

Expression of RNA and antigens of human immunodeficiency virus type-1 (HIV-1) in lymph nodes from HIV-1 infected individuals.

R. Broekhuizen, J. Goudsmit, H. Schuurman, 1988, The American journal of pathology.

Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022.

R. Baric, D. Wesemann, A. Griffiths, 2021, JCI insight.

Serum capacity to inhibit reverse transcriptase in vitro distinguishes HIV-1 infection from HIV-2 or SIV infection.

J. Goudsmit, H. Schellekens, J. Geelen, 1989, AIDS research and human retroviruses.

Determinants for the syncytium-inducing phenotype of HIV-1 subtype F isolates are located in the V3 region.

J. Goudsmit, J. D. de Jong, E. Baan, 2000, AIDS research and human retroviruses.

Characterization of the African HIV-1 isolate CBL-4 (RUT) by partial sequence analysis and virus neutralization with peptide antibody and antisense phosphate-methylated DNA.

C. Kuiken, J. Goudsmit, J. Geelen, 1990, AIDS.

Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults.

N. Foudraine, J. Goudsmit, S. Danner, 1999, The Journal of infectious diseases.

Low versus High CD4 Cell Count as Starting Point for Introduction of Antiretroviral Treatment in Resource-Poor Settings: A Scenario-Based Analysis

P. Bossuyt, R. Geskus, G. Weverling, 2003, Antiviral therapy.

Quantification of residual host cell DNA in adenoviral vectors produced on PER.C6 cells.

M. Havenga, J. Goudsmit, G. Marzio, 2005, Human gene therapy.

Potent peptidic fusion inhibitors of influenza virus

I. Wilson, R. Vreeken, Christophe Buyck, 2017, Science.

Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam.

J. Goudsmit, J. van der Noordaa, R. Coutinho, 1986, Genitourinary medicine.

Shortening of the Symptom-Free Period in Rhesus Macaques Is Associated with Decreasing Nonsynonymous Variation in theenv Variable Regions of Simian Immunodeficiency Virus SIVsm during Passage

J. Heeney, J. Goudsmit, V. Lukashov, 1998, Journal of Virology.

Structured-Tree Topology and Adaptive Evolution of the Simian Immunodeficiency Virus SIVsm Envelope during Serial Passage in Rhesus Macaques According to Likelihood Mapping and Quartet Puzzling

J. Goudsmit, P. J. Spencer Valli, 1998, Journal of Virology.

Qualitative and quantitative detection of HIV‐1 RNA by nucleic acid sequence‐based amplification

T. Kievits, J. Goudsmit, S. Jurriaans, 1993, AIDS.

Detection of Early Anti‐p24 HIV Responses in EIA‐ and Immunoblot‐Negative Individuals

J. Goudsmit, F. Miedema, P. Lelie, 1987, Vox sanguinis.

The rate of epidemiological and virological changes during the transition from nascent to concentrated HIV epidemic stage in the former Soviet Union countries.

R. Heimer, J. Goudsmit, A. Kozlov, 2007, AIDS research and human retroviruses.

Genetic evidence of multiple transmissions of HIV type 1 subtype F within Romania from adult blood donors to children.

J. Goudsmit, E. O. D. Op de Coul, M. Cornelissen, 2000, AIDS research and human retroviruses.

HIV type 1 subtypes in The Netherlands circulating among women originating from AIDS-endemic regions.

C. Kuiken, J. Goudsmit, V. Lukashov, 1996, AIDS research and human retroviruses.

Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic.

C. Kuiken, J. Goudsmit, G. Zwart, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Mechanisms of Hemagglutinin Targeted Influenza Virus Neutralization

Antoine M. van Oijen, A. V. van Oijen, V. Klaren, 2013, PloS one.

Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle level

A. V. van Oijen, Samaneh Mashaghi, Boerries Brandenburg, 2014, Proceedings of the National Academy of Sciences.

Longitudinal study of leukocyte functions in homosexual men seroconverted for HIV: rapid and persistent loss of B cell function after HIV infection

F. Miedema, J. Goudsmit, F. Wolf, 1989, European journal of immunology.

HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic Acids

Martin H. Koldijk, F. Cox, V. Klaren, 2016, Front. Immunol..

Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity

J. Goudsmit, W. Keulen, B. Klaver, 1992, Journal of virology.

Hamster scrapie: evidence for alterations in serotonin metabolism.

L. Neckers, D. Gajdusek, J. Goudsmit, 1981, Advances in experimental medicine and biology.

Quantitative Measurement of Vitamin B1 by the Thiochrome Reaction

J. Goudsmit, H. G. K. WESTENBRINK, 1938, Nature.

Aneurin excretion after injection of cocarboxylase.

J. Goudsmit, H. Westenbrink, 1940 .

Neutralizing antibodies are positively associated with CD4+ T‐cell counts and T‐cell function in long‐term AIDS‐free infection

J. Goudsmit, F. de Wolf, P. Carotenuto, 1998, AIDS.

Twenty-seven-year time trends in dementia incidence in Europe and the United States

M. Fornage, A. Hofman, V. Gudnason, 2020, Neurology.

Lower complexity and higher variability in beat‐to‐beat systolic blood pressure are associated with elevated long‐term risk of dementia: The Rotterdam Study

A. Hofman, B. Westerhof, L. Lipsitz, 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

transfer serotype 5 hexon: effect of mutagenesis on FX interactions and gene Identification of coagulation factor (F)X binding sites on the adenovirus

D. Bhella, N. Rooijen, A. Parker, 2011 .

Immunological memory to hyperphosphorylated tau in asymptomatic individuals

I. Wilson, Z. Fulton, J. Hoozemans, 2017, Acta Neuropathologica.

IgG Antibodies to SAIDS-D Virus Associated Antigens in Patients with AIDS and at Risk for AIDS

D. Gajdusek, J. Goudsmit, J. Sever, 1985 .

Immunoglobulin subclasses of antibodies to human T-cell leukemia/lymphoma virus I-associated antigens in acquired immune deficiency syndrome and lymphadenopathy syndrome

J. Goudsmit, J. van der Noordaa, M. Roos, 1985, Journal of virology.

Antibody response to the viral negative factor (nef) in HIV-1 infection: a correlate of levels of HIV-1 expression.

C. Debouck, P. Reiss, J. Goudsmit, 1989, AIDS.

Low antigenicity of HIV-1 rev: rev-specific antibody response of limited value as correlate of rev gene expression and disease progression.

C. Debouck, P. Reiss, J. Goudsmit, 1989, AIDS research and human retroviruses.

Serum reactivity to HIV-1 accessory gene products distinguishes East African from West African HIV strains as infecting agent.

C. Debouck, C. Boucher, J. Goudsmit, 1989, AIDS research and human retroviruses.

CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage.

R. Lal, J. Goudsmit, A. Lal, 1998, Virology.

Characteristics of primary infection of a European human immunodeficiency virus type 1 clade B isolate in chimpanzees.

H. Schuitemaker, J. Heeney, H. Niphuis, 1998, The Journal of general virology.

Diagnostic value of specific IgM antibodies in primary HIV infection.

J. Parry, J. Goudsmit, F. de Wolf, 1988, AIDS.

Viral Fitness: The Next SARS and West Nile in the Making

J. Goudsmit, 2004 .

Title Heterosubtypic neutralizing monoclonal antibodies cross-protective against H 5 N 1 and H 1 N 1 recovered from human IgM + memory B cells

Y. Guan, L. Poon, I. Lasters, 2008 .

First case of new infection with zidovudine-resistant HIV-1 among prospectively studied intravenous drug users and homosexual men in Amsterdam, The Netherlands.

C. Boucher, J. Goudsmit, R. Schuurman, 1996, AIDS.

A comparison of serum HIV-1 RNA levels as measured by two quantitative assays in zidovudine-treated, asymptomatic, HIV-infected individuals.

G. Weverling, J. Goudsmit, M. D. de Jong, 1996, Antiviral therapy.

Mummies of Olive Baboons and Barbary Macaques in the Baboon Catacomb of the Sacred Animal Necropolis at North Saqqara *

J. Goudsmit, D. Brandon-Jones, 1999 .

A replication-competent adenovirus assay for E1-deleted Ad35 vectors produced in PER.C6 cells.

A. D. De Groot, G. Weverling, M. Havenga, 2007, Vaccine.

Common Structure of Rare Replication-Deficient E1-Positive Particles in Adenoviral Vector Batches

J. Files, M. Havenga, R. Vogels, 2004, Journal of Virology.

Frequent and early HIV-1MN neutralizing capacity in sera from Dutch HIV-1 seroconverters is related to antibody reactivity to peptides from the gp120 V3 domain.

L. van der Hoek, J. Goudsmit, G. Zwart, 1994, AIDS research and human retroviruses.

Presentation and course of AIDS dementia complex

P. Algra, P. Portegies, J. Goudsmit, 1993 .

Regression of AIDS-related Kaposi's sarcoma associated with clearance of human herpesvirus-8 from peripheral blood mononuclear cells following initiation of antiretroviral therapy.

P. Reiss, F. Wit, J. Goudsmit, 1998, AIDS.

Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees

R. Gallo, J. Goudsmit, P. Nara, 1990, Journal of virology.

Spread of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa.

J. Goudsmit, M. Cornelissen, F. Zorgdrager, 2000, The Journal of general virology.

Low prevalence of human T‐cell leukemia virus‐I and ‐II infection among drug users in Amsterdam, the Netherlands

J. Goudsmit, R. Coutinho, J. V. D. van den Hoek, 1991, Journal of medical virology.

Adapted from: Recent progress in understanding parasite biology, pathology and disease in malaria: translation of knowledge into novel malaria vaccines.

J. Goudsmit, A. Luty, O. Ophorst, 2007 .

Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression.

C. Kuiken, L. van der Hoek, J. Goudsmit, 1994, Virology.

IgG response to human immunodeficiency virus in experimentally infected chimpanzees mimics the IgG response in humans.

L. Epstein, D. Gajdusek, J. Goudsmit, 1987, Journal of Infectious Diseases.

Predictors of rapid progression to AIDS in HIV-1 seroconverters.

P. Krijnen, I. Keet, J. Goudsmit, 1993, AIDS.

Rapid CD4+ T-lymphocyte depletion in rhesus monkeys infected with a simian-human immunodeficiency virus expressing the envelope glycoproteins of a primary dual-tropic Ethiopian Clade C HIV type 1 isolate.

J. Sodroski, N. Letvin, M. Axthelm, 2004, AIDS research and human retroviruses.

Map of sequential B cell epitopes of the HIV-1 transmembrane protein using human antibodies as probe.

R. Brasseur, R. Meloen, J. Goudsmit, 1990, Intervirology.

Trafficking of Antigen-Specific CD8+ T Lymphocytes to Mucosal Surfaces following Intramuscular Vaccination1

K. Mansfield, D. Kaufman, M. Havenga, 2008, The Journal of Immunology.

Immunodominant B-cell clones responsive to an HIV-1 neutralization and cell fusion inhibition epitope in chimpanzee-to-chimpanzee passages of HTLV-IIIB and LAV-1.

J. Goudsmit, M. Bakker, L. Smit, 1989, Research in virology.

Antibody recognition of amino acid divergence within an HIV-1 neutralization epitope.

C. Kuiken, L. Epstein, J. Goudsmit, 1989, Research in virology.

Characterization of human antibody-binding sites on the external envelope of human immunodeficiency virus type 2.

R. Meloen, J. Goudsmit, F. de Wolf, 1991, The Journal of general virology.

Seroconversion to HIV-1 rev- and tat-gene-encoded proteins.

C. Debouck, P. Reiss, J. Goudsmit, 1989, AIDS.

Antibodies to the Human T‐Cell Lymphoma/Leukemia Virus Type I in Dutch Haemophiliacs

J. Goudsmit, M. Roos, P. Schellekens, 1986, Vox sanguinis.

Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodies

J. Goudsmit, M. Schutten, M Schutten, 1993, Journal of virology.

Maternal antibodies protect offspring from severe influenza infection and do not lead to detectable interference with subsequent offspring immunization

K. Radošević, R. Roozendaal, J. Vreugdenhil, 2017, Virology Journal.

Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants.

H. Schuitemaker, A. M. de Roda Husman, J. Goudsmit, 1998, The Journal of infectious diseases.

Epitopes of human immunodeficiency virus regulatory proteins tat, nef, and rev are expressed in normal human tissue.

J. Goudsmit, H. Schuurman, D. V. van Wichen, 1992, The American journal of pathology.

Antibody response to a synthetic peptide covering a LAV-1/HTLV-IIIB neutralization epitope and disease progression.

C. Boucher, J. Goudsmit, F. de Wolf, 1989, AIDS.

Persistence of human immunodeficiency virus antigenemia in patients with the acquired immunodeficiency syndrome treated with a reverse transcriptase inhibitor, suramin. Ten-patient case-control study.

J. Goudsmit, S. Danner, J. Lange, 1988, Archives of internal medicine.

Surveillance technology for HIV-1 subtype C in Ethiopia: an env-based NASBA molecular beacon assay to discriminate between subcluster C and C'.

Jaap Goudsmit, Dawit Wolday, Georgios Pollakis, 2005, Journal of virological methods.

Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine

F. Cox, K. Radošević, L. Dekking, 2015, Virology Journal.

Independent introduction of transmissible F/D recombinant HIV-1 from Africa into Belgium and The Netherlands.

J. Goudsmit, L. Heyndrickx, E. O. D. Coul, 2000, Virology.

A common antigenic motif recognized by naturally occurring human VH5–51/VL4–1 anti-tau antibodies with distinct functionalities

Martin H. Koldijk, S. Steinbacher, I. Wilson, 2018, Acta neuropathologica communications.

Impairment of in vitro immune responses occurs within 3 months after HIV-1 seroconversion.

A. Osterhaus, J. Goudsmit, F. de Wolf, 1990, AIDS.

HIV1 3' ORF is open in pathological tissue and accelerates viral replication in primary lymphocytes.

L. Epstein, J. Goudsmit, B. Blumberg, 1992, Research in virology.

Cells Cell-Stimulating Skin-Emigrated Dendritic T + Transduction of Mature , CD 8 Vectors Leads to High Efficiency Intradermal Delivery of Adenoviral Type-35

M. Havenga, J. Goudsmit, R. Scheper, 2006 .

Evaluation of different V3 peptides in an enzyme immunoassay for specific HIV type 1 group O antibody detection.

B. Korber, M. Peeters, J. Goudsmit, 1998, AIDS research and human retroviruses.

SEROCONVERSION TO HIV-1 NEGATIVE REGULATION FACTOR

C. Debouck, P. Reiss, J. Goudsmit, 1988, The Lancet.

Serum antibodies to HTLV‐I in human demyelinating disease

L. Epstein, J. Goudsmit, J. Crowley, 1987, Acta neurologica Scandinavica.

Timing of human immunodeficiency virus type 1 and human herpesvirus 8 infections and length of the Kaposi's sarcoma-free period in coinfected persons.

T. Schulz, G. Weverling, J. Goudsmit, 2001, The Journal of infectious diseases.

Impact of sexual versus parenteral transmission events on the evolution of the gag and env genes of HIV type 1.

J. Goudsmit, M. Cornelissen, V. Lukashov, 1998, AIDS Research and Human Retroviruses.

Prediction of Residual Time to AIDS and Death Based on Markers and Cofactors

Peter Reiss, Ronald B Geskus, Jaap Goudsmit, 2003, Journal of acquired immune deficiency syndromes.

Differences in human immunodeficiency virus type 1 V3 sequences from patients with and without AIDS dementia complex.

C. Kuiken, P. Portegies, J. Goudsmit, 1995, The Journal of general virology.

Epidemiology of HIV-1 and emerging problems.

J. Goudsmit, V. Lukashov, J. D. de Jong, 2000, International journal of antimicrobial agents.

A proteomic approach to tumour target identification using phage display, affinity purification and mass spectrometry.

Jaap Goudsmit, F. Cox, J. de Kruif, 2005, European journal of cancer.

T cell telomere length in HIV-1 infection: No evidence for increased CD4+ T cell turnover☆

Niels Schaft, Jaap Goudsmit, Linde Meyaard, 1997 .

[Zidovudine-resistant HIV strains in intravenous drug users and homosexual men in Amsterdam].

J. Goudsmit, R. Coutinho, E. de Rooij, 1996, Nederlands tijdschrift voor geneeskunde.

Routine DNA analysis based on 12S rRNA gene sequencing as a tool in the management of captive primates.

J. Goudsmit, A. C. van der Kuyl, J. Dekker, 2000, Journal of medical primatology.

Primate genus Miopithecus: evidence for the existence of species and subspecies of dwarf guenons based on cellular and endogenous viral sequences.

J. Goudsmit, A. C. van der Kuyl, J. Dekker, 2000, Molecular phylogenetics and evolution.

Maintenance of syncytium-inducing phenotype of HIV type 1 is associated with positively charged residues in the HIV type 1 gp120 V2 domain without fixed positions, elongation, or relocated N-linked glycosylation sites.

J. Goudsmit, M. Cornelissen, F. Zorgdrager, 1995, AIDS research and human retroviruses.

Quantification of biological age as a determinant of age-related diseases in the Rotterdam Study: a structural equation modeling approach

A. Hofman, M. Ikram, H. Tiemeier, 2019, European Journal of Epidemiology.

[Primary infections with human immunodeficiency virus].

J. Goudsmit, J. Lange, F. A. Claessen, 1990, Nederlands tijdschrift voor geneeskunde.

[LAV/HTLV-III infection after a one-time sexual contact with an AIDS patient].

P. Reiss, J. Goudsmit, J. Lange, 1985, Nederlands tijdschrift voor geneeskunde.

Production and characterization of a human monoclonal antibody, reactive with a conserved epitope on gp41 of human immunodeficiency virus type I.

A. Osterhaus, J. Goudsmit, K. Siebelink, 1990, AIDS research and human retroviruses.

V3 loop sequence analysis of seven HIV type 1 group O isolates phenotyped in peripheral blood mononuclear cells and MT-2 cells.

F. Brun-Vézinet, J. Goudsmit, S. Saragosti, 1996, AIDS research and human retroviruses.

Transmission of zidovudine-resistant human immunodeficiency virus type 1 variants following deliberate injection of blood from a patient with AIDS: characteristics and natural history of the virus.

H. Schuitemaker, C. Boucher, J. Veenstra, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

First-in-human phase 1 trial of the safety and immunogenicity of a recombinant adenovirus serotype 5 HVR48 (rAd5HVR48) HIV-1 vaccine

J. Goudsmit, M. Seaman, M. Weijtens, 2012, Retrovirology.

High-dose interferon-alpha2a exerts potent activity against human immunodeficiency virus type 1 not associated with antitumor activity in subjects with Kaposi's sarcoma.

P. Reiss, J. Goudsmit, F. de Wolf, 1997, The Journal of infectious diseases.

Silent mutation in the V3 region characteristic of HIV type 1 env subtype B strains from injecting drug users in the former Soviet Union.

J. Weber, J. Goudsmit, V. Lukashov, 2000, AIDS research and human retroviruses.

Discovery of a New Endogenous Type C Retrovirus (FcEV) in Cats: Evidence for RD-114 Being an FcEVGag-Pol/Baboon Endogenous Virus BaEVEnv Recombinant

J. Goudsmit, A. C. van der Kuyl, J. Dekker, 1999, Journal of Virology.

An evaluation of HIV RNA and CD4 cell count as surrogates for clinical outcome. Delta Coordinating Committee and Virology Group.

Abdel Babiker, Philippe Flandre, Peter Reiss, 1999, AIDS.

Antigen-driven CD 4 1 T cell and HIV-1 dynamics : Residual viral replication under highly active antiretroviral therapy

C. Fraser, A. Ghani, C. Donnelly, 1999 .

HIV type 1 C and C' subclusters based on long terminal repeat sequences in the Ethiopian type 1 subtype C epidemic.

J. Goudsmit, G. Pollakis, A. Kliphuis, 2003, AIDS research and human retroviruses.

Universal cellular tropism?

H. Kung, J. Goudsmit, P. Nara, 1992, Nature.

HIV-1 tropism: truth or consequences?

H. Kung, J. Goudsmit, P. Nara, 1992, AIDS research and human retroviruses.

Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudine.

J. Goudsmit, F. de Wolf, S. Danner, 1988, AIDS.

Fractionation of nucleic acids into single-stranded and double-stranded forms

Jaap Goudsmit, Marcel Beld, Cees Sol, 1996, Nucleic Acids Res..

Common antigenic motif recognized by human VH5-51/VL4-1 tau antibodies with distinct functionalities

Martin H. Koldijk, S. Steinbacher, I. Wilson, 2018, bioRxiv.

Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine

Martin H. Koldijk, F. Cox, K. Radošević, 2015, Virology Journal.

Approaches to the development of broadly protective HIV vaccines: challenges posed by the genetic, biological and antigenic variability of HIV-1: Report* from a meeting of the WHO-UNAIDS Vaccine Advisory Committee** Geneva, 21–23 February 2000

Guido Ferrari, N. Nathanson, Donald S. Burke, 2001, AIDS.

Immune Protection of Nonhuman Primates against Ebola Virus with Single Low-Dose Adenovirus Vectors Encoding Modified GPs

R. Koup, N. Sullivan, P. Jahrling, 2006, PLoS medicine.

reply: Dating the origin of HIV-1 subtypes

J. Goudsmit, V. Lukashov, 1999, Nature.

[Decreased incidence in HIV infection and changed sex behavior in a cohort of homosexual men in Amsterdam].

J. Goudsmit, R. Coutinho, E. D. de Vroome, 1989, Nederlands tijdschrift voor geneeskunde.

Papio cynocephalus Endogenous Retrovirus among Old World Monkeys: Evidence for Coevolution and Ancient Cross-Species Transmissions

J. Goudsmit, A. C. van der Kuyl, R. Mang, 2000, Journal of Virology.

Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity

S. Kostense, P. Quax, M. Havenga, 2003, Journal of Virology.

Mitochondrial toxicity of HIV-1 infection and its treatment

P. Reiss, J. Goudsmit, A. D. Ronde, 2007 .

The Th1 Immune Response to Plasmodium falciparum Circumsporozoite Protein Is Boosted by Adenovirus Vectors 35 and 26 with a Homologous Insert

A. Lemckert, K. Radošević, J. Goudsmit, 2010, Clinical and Vaccine Immunology.

Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.

G. Weverling, M. Zambon, K. Radošević, 2008, Vaccine.

PRODUCTIVE HTLV-III INFECTION OF HUMAN B CELL LINES

J. Goudsmit, F. Miedema, M. Tersmette, 1985, The Lancet.

Lack of in vivo compartmentalization among HIV-1 infected naïve and memory CD4+ T cell subsets.

R. Koup, D. Douek, J. Brenchley, 2009, Virology.

Hypersensitivity to central serotonin receptor activation in scrapie-infected hamsters and the effect of serotonergic drugs on scrapie symptoms

E. Silbergeld, D. Gajdusek, J. Goudsmit, 1981, Brain Research.

Binding of HIV-1 to human follicular dendritic cells.

M. Visser, J. Verhoef, T. Meerloo, 1993, Advances in Experimental Medicine and Biology.

Evidence for rapid selection and deletion of HIV-1 subpopulations in vivo by V3-specific neutralizing antibody: a model of humoral-associated selection.

J. Goudsmit, P. Nara, L. Smit, 1990, Developments in biological standardization.

Neutralizing Antiviral Antibodies Reduce Hematogenic Viral Spread but Not Antiviral Cytotoxic T Cell Induction and Subsequent Immunopathology

G. Weverling, J. Goudsmit, N. Renwick, 2001 .

Ongoing HIV dissemination during HAART

Jaap Goudsmit, Zehava Grossman, Z. Grossman, 1999, Nature Medicine.

Human Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment Step

T. Pierson, M. Diamond, S. Austin, 2009, Journal of Virology.

Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent.

J. Verhoef, T. Meerloo, J. Goudsmit, 1993, Journal of immunology.

Dating the origin of HIV-1 subtypes

J. Goudsmit, V. Lukashov, 1999, Nature.

Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

V. A. Stewart, J. Wittes, M. Thera, 2005, Vaccine.